Search results
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 5 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 6 days agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 6 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks· 6 days agoPfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 6 days agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 3 days agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
Pfizer Inc. [PFE] Investment Appeal on the Rise – Knox Daily
Knox Daily· 1 day agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 3 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...